Incertae sedis

From WikiMD's WELLNESSPEDIA

Incertae sedis is a term used in the field of taxonomy to refer to a taxonomic group where its broader relationships are unknown or undefined. The term is Latin for "of uncertain placement" and is often used for taxa when the phylogenetic relationships are unclear.

Definition[edit]

The term Incertae sedis (Latin for 'of uncertain placement') is often used in the classification of organisms where the taxonomic position is uncertain or undefined. It is used in situations where further research is needed to determine the phylogenetic relationships and classification of a particular group of organisms.

Usage in Taxonomy[edit]

In taxonomy, the term Incertae sedis is used to denote a taxonomic group where its broader relationships are unknown or undefined. This can occur when the characteristics of the group do not match the criteria used to define the existing taxa, or when the phylogenetic relationships are unclear. The term is often used in the context of phylogenetic trees, where it denotes a group of organisms that cannot be placed in any particular branch of the tree.

Examples[edit]

Examples of taxa that are currently classified as Incertae sedis include the bacterial phylum Armatimonadetes, the fungal class Geoglossomycetes, and the animal phylum Placozoa. These groups are all characterized by a lack of clear phylogenetic relationships with other groups, and their classification as Incertae sedis reflects the current state of knowledge in their respective fields.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.